YD Bio and EG BioMed Expand U.S. Access to OkaiDx™, a cfDNA‑Methylation Blood Test for Post‑Treatment Breast Cancer Monitoring

The test has been reported in peer‑reviewed journals such as Clinical Epigenetics and Biomolecules, and presented at major oncology conferences. EG BioMed’s CLIA and CAP accreditation enables U.S.

New method makes transgene-free gene editing even more promising

Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...

Man’s Best Friend! Tom Brady Reveals His Dog Is a Clone of the Family’s Late Pit Bull Mix — as NFL Legend Backs Innovative Bioscience Company

Tom Brady has revealed that his young pit bull mix Junie is actually a clone of his beloved late dog Lua, RadarOnline. com ...

Biotech company Colossal, which brought dire wolves back to life, acquires Viagen

Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...

KATMAP: A new way to understand and predict gene splicing

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

The race is on to turn your body into a GLP-1 factory

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...
Hub

Nobel laureate Hamilton Smith, who discovered molecular 'scissors' to cut DNA, dies at 94

Smith, a microbiologist whose discovery revolutionize the field of genetic engineering, was a Johns Hopkins School of ...
TipRanks on MSN

Precision Biotech Wave Builds As FDA Expedites Breakthrough Cell And Gene Therapies

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached $119 billion in ...